The saliva collection devices market comprises products such as saliva collection tubes, swabs, and cassettes that are used to collect and store unstimulated or stimulated saliva samples. Saliva collection devices offer a non-invasive alternative to sample collection methods involving blood draws or other clinical procedures. These devices make the sampling process convenient and pain-free for both patients and healthcare professionals. The increasing focus on precision medicine and disease diagnostics using omics technologies such as genomics, proteomics and metabolomics is driving the demand for collecting biological samples in a simple, cost-effective manner.

The Global saliva collection devices market is estimated to be valued at US$ 342.46 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the saliva collection devices are IBM Corporation, Oracle Corporation, Cerner Corporation, InterSystems Corporation, Allscripts Healthcare Solutions, Red Hat, Inc. (acquired by IBM), Microsoft Corporation, GE Healthcare, Infor, Inc., Epic Systems Corporation, TIBCO Software Inc., McKesson Corporation, Dell Technologies, Informatica Corporation, Ascom Holding AG . The demand for saliva collection devices is increasing owing to the growing adoption of saliva-based testing for various clinical diagnostic purposes such as the detection of COVID-19, drugs of abuse and chronic diseases monitoring. Major technological advancements have been witnessed in the field of salivary diagnostics with the development of novel platforms for integrated fluid handling, biomarker detection and data interpretation from saliva samples

Market trends

The saliva collection devices market size is witnessing trend of product development focused on home collection kits. Manufacturers are developing self-collection kits that can be easily used at home and shipped to laboratories for testing. This helps in expanding access to tests and healthcare. Another emerging trend is integrated fluidic systems that allow automated extraction, purification and analysis of biomarkers from saliva samples on a single portable platform.

Market Opportunities

Growing demand for non-invasive methods for disease monitoring and screening in healthcare represents a major opportunity. Development of inexpensive, microfluidic-based "labs-on-chip" for integrating all steps of saliva sample collection, biomarker isolation and detection on a single compact device will boost the market potential. Emerging economies with large patient pools such as India and China offer lucrative growth opportunities owing to increasing healthcare investments.

Impact of COVID-19 on Saliva Collection Devices Market Growth:

The outbreak of the COVID-19 pandemic has significantly impacted the growth of the global saliva collection devices market. During the initial lockdown phases, healthcare facilities were overwhelmed and focused more on testing and treating COVID-19 patients. This led to postponing of several non-COVID procedures which utilized saliva collection devices. Moreover, disruptions in the supply chain and international trade restrictions affected the procurement of raw materials for manufacturing saliva collection devices. However, as the pandemic progressed, detecting SARS-CoV-2 infection through saliva-based RT-PCR testing became a preferred method owing to its ease of collection compared to nasopharyngeal swabs. This boosted the demand for saliva collection devices from 2020 onwards. Going forward, as vaccination drives help regain control over the virus spread, utilization of saliva testing is expected to remain popular even in the post-pandemic scenario for screening purposes in schools, workplaces and airports. Device manufacturers will need to focus on ramping up production capacities, ensuring supply chain reliability and exploring new markets to sustain the growth momentum.

Regional Concentration in Saliva Collection Devices Market:

In terms of value, North America accounted for the major share of the global saliva collection devices market in 2024. This can be primarily attributed to the advanced healthcare infrastructure and rising emphasis on preventive healthcare approach in the region. For instance, employers in the United States have started implementing regular saliva-based COVID-19 screening for employees returning to workplaces. Additionally, growing awareness about early disease detection and favorable reimbursement policies for diagnostic tests are fueling the adoption of saliva collection devices across different end-users in the region.

Fastest Growing Region for Saliva Collection Devices Market:

Asia Pacific is poised to experience the fastest growth in the saliva collection devices market during the forecast period. This can be accredited to increasing healthcare expenditure, rising disposable income, growing geriatric population susceptible to chronic diseases and rapid development of healthcare research infrastructure in emerging economies such as China and India. Moreover, large patient pools suffering from infectious diseases and various forms of cancers are driving the need for cost-effective and non-invasive screening and testing methods using saliva samples. Continuous technological advancements and rising collaborations between regional and international market players are further expected to boost market expansion across the Asia Pacific region.

Get more insights on: Saliva Collection Devices Market